SA92130072B1 - خلية إلكترونية electrolytic cell وعملية لوسم او تعليم labeling البروتينات - Google Patents
خلية إلكترونية electrolytic cell وعملية لوسم او تعليم labeling البروتينات Download PDFInfo
- Publication number
- SA92130072B1 SA92130072B1 SA92130072A SA92130072A SA92130072B1 SA 92130072 B1 SA92130072 B1 SA 92130072B1 SA 92130072 A SA92130072 A SA 92130072A SA 92130072 A SA92130072 A SA 92130072A SA 92130072 B1 SA92130072 B1 SA 92130072B1
- Authority
- SA
- Saudi Arabia
- Prior art keywords
- working electrode
- aforementioned
- cell
- electrode
- half cell
- Prior art date
Links
- 238000002372 labelling Methods 0.000 title claims abstract description 26
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 21
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 21
- 238000000034 method Methods 0.000 title claims description 58
- 230000008569 process Effects 0.000 title claims description 34
- 230000002285 radioactive effect Effects 0.000 claims abstract description 31
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 16
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 12
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims description 34
- 229910052751 metal Inorganic materials 0.000 claims description 22
- 239000002184 metal Substances 0.000 claims description 22
- 239000012528 membrane Substances 0.000 claims description 21
- 239000000463 material Substances 0.000 claims description 19
- 239000010931 gold Substances 0.000 claims description 17
- 239000003795 chemical substances by application Substances 0.000 claims description 16
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 16
- 229910052737 gold Inorganic materials 0.000 claims description 16
- 229910052697 platinum Inorganic materials 0.000 claims description 15
- 239000003011 anion exchange membrane Substances 0.000 claims description 9
- 150000004820 halides Chemical class 0.000 claims description 9
- 238000005341 cation exchange Methods 0.000 claims description 7
- 230000008021 deposition Effects 0.000 claims description 5
- 238000000163 radioactive labelling Methods 0.000 claims description 5
- 239000010948 rhodium Substances 0.000 claims description 5
- 229910001220 stainless steel Inorganic materials 0.000 claims description 5
- 239000010935 stainless steel Substances 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 229910052703 rhodium Inorganic materials 0.000 claims description 3
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 claims description 3
- 229910045601 alloy Inorganic materials 0.000 claims 1
- 239000000956 alloy Substances 0.000 claims 1
- 239000007772 electrode material Substances 0.000 claims 1
- 230000005012 migration Effects 0.000 claims 1
- 238000013508 migration Methods 0.000 claims 1
- 238000001179 sorption measurement Methods 0.000 abstract description 9
- 230000003647 oxidation Effects 0.000 abstract description 4
- 238000007254 oxidation reaction Methods 0.000 abstract description 4
- 210000004027 cell Anatomy 0.000 description 72
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 51
- 229910052740 iodine Inorganic materials 0.000 description 50
- 239000011630 iodine Substances 0.000 description 50
- 238000005868 electrolysis reaction Methods 0.000 description 29
- 239000000243 solution Substances 0.000 description 27
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 22
- 238000011282 treatment Methods 0.000 description 20
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 18
- 229910052736 halogen Inorganic materials 0.000 description 18
- 150000002367 halogens Chemical class 0.000 description 18
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 18
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 14
- 239000000203 mixture Substances 0.000 description 13
- 239000000047 product Substances 0.000 description 13
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 238000003756 stirring Methods 0.000 description 12
- 239000002904 solvent Substances 0.000 description 11
- 229960004441 tyrosine Drugs 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 10
- 239000003792 electrolyte Substances 0.000 description 10
- 239000011521 glass Substances 0.000 description 10
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 238000002474 experimental method Methods 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 8
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 8
- 230000026030 halogenation Effects 0.000 description 8
- 238000005658 halogenation reaction Methods 0.000 description 8
- -1 polypropylene Polymers 0.000 description 8
- 229910021607 Silver chloride Inorganic materials 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 229960003399 estrone Drugs 0.000 description 7
- 239000003550 marker Substances 0.000 description 7
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 7
- DNXHEGUUPJUMQT-UHFFFAOYSA-N (+)-estrone Natural products OC1=CC=C2C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 DNXHEGUUPJUMQT-UHFFFAOYSA-N 0.000 description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- DNXHEGUUPJUMQT-CBZIJGRNSA-N Estrone Chemical compound OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 DNXHEGUUPJUMQT-CBZIJGRNSA-N 0.000 description 6
- 239000010405 anode material Substances 0.000 description 6
- 230000004048 modification Effects 0.000 description 6
- 238000012986 modification Methods 0.000 description 6
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 230000008901 benefit Effects 0.000 description 5
- 239000003480 eluent Substances 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- KDPQTPZDVJHMET-UHFFFAOYSA-N 3-acetoxy-1,3,5(10)-estratrien-17-one Natural products C1CC2(C)C(=O)CCC2C2CCC3=CC(OC(=O)C)=CC=C3C21 KDPQTPZDVJHMET-UHFFFAOYSA-N 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- KDPQTPZDVJHMET-XSYGEPLQSA-N [(8r,9s,13s,14s)-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6h-cyclopenta[a]phenanthren-3-yl] acetate Chemical compound C1C[C@]2(C)C(=O)CC[C@H]2[C@@H]2CCC3=CC(OC(=O)C)=CC=C3[C@H]21 KDPQTPZDVJHMET-XSYGEPLQSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 4
- 239000003054 catalyst Substances 0.000 description 4
- 239000004020 conductor Substances 0.000 description 4
- 230000001276 controlling effect Effects 0.000 description 4
- 229920001971 elastomer Polymers 0.000 description 4
- 238000001962 electrophoresis Methods 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 150000002739 metals Chemical class 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 239000000741 silica gel Substances 0.000 description 4
- 229910002027 silica gel Inorganic materials 0.000 description 4
- 238000001228 spectrum Methods 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- 238000004809 thin layer chromatography Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 229920000557 Nafion® Polymers 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 125000002091 cationic group Chemical group 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000000151 deposition Methods 0.000 description 3
- 230000026045 iodination Effects 0.000 description 3
- 238000006192 iodination reaction Methods 0.000 description 3
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 3
- 239000010452 phosphate Substances 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 238000002791 soaking Methods 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- LAIUFBWHERIJIH-UHFFFAOYSA-N 3-Methylheptane Chemical compound CCCCC(C)CC LAIUFBWHERIJIH-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- NKANXQFJJICGDU-QPLCGJKRSA-N Tamoxifen Chemical compound C=1C=CC=CC=1C(/CC)=C(C=1C=CC(OCCN(C)C)=CC=1)/C1=CC=CC=C1 NKANXQFJJICGDU-QPLCGJKRSA-N 0.000 description 2
- IZAINEOEAWYLJO-UHFFFAOYSA-N [Tc].[Re] Chemical compound [Tc].[Re] IZAINEOEAWYLJO-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- YADSGOSSYOOKMP-UHFFFAOYSA-N dioxolead Chemical compound O=[Pb]=O YADSGOSSYOOKMP-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 229940011871 estrogen Drugs 0.000 description 2
- 239000000262 estrogen Substances 0.000 description 2
- 102000015694 estrogen receptors Human genes 0.000 description 2
- 108010038795 estrogen receptors Proteins 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 238000003818 flash chromatography Methods 0.000 description 2
- XMBWDFGMSWQBCA-UHFFFAOYSA-M iodide Chemical compound [I-] XMBWDFGMSWQBCA-UHFFFAOYSA-M 0.000 description 2
- SNHMUERNLJLMHN-UHFFFAOYSA-N iodobenzene Chemical compound IC1=CC=CC=C1 SNHMUERNLJLMHN-UHFFFAOYSA-N 0.000 description 2
- 239000003014 ion exchange membrane Substances 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 238000003760 magnetic stirring Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 229910000510 noble metal Inorganic materials 0.000 description 2
- MUMZUERVLWJKNR-UHFFFAOYSA-N oxoplatinum Chemical compound [Pt]=O MUMZUERVLWJKNR-UHFFFAOYSA-N 0.000 description 2
- 229910003446 platinum oxide Inorganic materials 0.000 description 2
- 239000004417 polycarbonate Substances 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 230000006318 protein oxidation Effects 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000000171 quenching effect Effects 0.000 description 2
- 239000012266 salt solution Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 229910052709 silver Inorganic materials 0.000 description 2
- 239000004332 silver Substances 0.000 description 2
- JHJLBTNAGRQEKS-UHFFFAOYSA-M sodium bromide Chemical compound [Na+].[Br-] JHJLBTNAGRQEKS-UHFFFAOYSA-M 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 235000009518 sodium iodide Nutrition 0.000 description 2
- 125000006850 spacer group Chemical group 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- UOZVHDAXQMQYHZ-FPPVNLLCSA-N (8R,9S,13S,14S)-15-bromo-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)(C(CC4Br)O)[C@@H]4[C@@H]3CCC2=C1 UOZVHDAXQMQYHZ-FPPVNLLCSA-N 0.000 description 1
- DQQMDOLPKAVVIE-HASHYOOPSA-N (8r,9s,13s,14s)-17-[(e)-2-iodanylethenyl]-13-methyl-7,8,9,11,12,14,15,16-octahydro-6h-cyclopenta[a]phenanthrene-3,17-diol Chemical class OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)(O)\C=C\[125I])[C@@H]4[C@@H]3CCC2=C1 DQQMDOLPKAVVIE-HASHYOOPSA-N 0.000 description 1
- UQTZMGFTRHFAAM-ZETCQYMHSA-N 3-iodo-L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(I)=C1 UQTZMGFTRHFAAM-ZETCQYMHSA-N 0.000 description 1
- 241000270728 Alligator Species 0.000 description 1
- 241001135931 Anolis Species 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 206010068051 Chimerism Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 101150105088 Dele1 gene Proteins 0.000 description 1
- 241000557769 Iodes Species 0.000 description 1
- HETCEOQFVDFGSY-UHFFFAOYSA-N Isopropenyl acetate Chemical compound CC(=C)OC(C)=O HETCEOQFVDFGSY-UHFFFAOYSA-N 0.000 description 1
- 229920005479 Lucite® Polymers 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 101710109488 Salt stress-induced protein Proteins 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- COLPVQJXGMBCRX-UHFFFAOYSA-N [I].[Au] Chemical compound [I].[Au] COLPVQJXGMBCRX-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 230000001833 anti-estrogenic effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000010425 asbestos Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 238000001354 calcination Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000005234 chemical deposition Methods 0.000 description 1
- 238000000170 chemical ionisation mass spectrum Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- WBZKQQHYRPRKNJ-UHFFFAOYSA-L disulfite Chemical compound [O-]S(=O)S([O-])(=O)=O WBZKQQHYRPRKNJ-UHFFFAOYSA-L 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 238000000840 electrochemical analysis Methods 0.000 description 1
- 238000004070 electrodeposition Methods 0.000 description 1
- 239000008151 electrolyte solution Substances 0.000 description 1
- 239000000328 estrogen antagonist Substances 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- 238000002143 fast-atom bombardment mass spectrum Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000005337 ground glass Substances 0.000 description 1
- 230000002140 halogenating effect Effects 0.000 description 1
- 239000000383 hazardous chemical Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 238000005470 impregnation Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000011221 initial treatment Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- ICIWUVCWSCSTAQ-UHFFFAOYSA-M iodate Chemical compound [O-]I(=O)=O ICIWUVCWSCSTAQ-UHFFFAOYSA-M 0.000 description 1
- XMBWDFGMSWQBCA-RNFDNDRNSA-M iodine-131(1-) Chemical compound [131I-] XMBWDFGMSWQBCA-RNFDNDRNSA-M 0.000 description 1
- 125000002346 iodo group Chemical group I* 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- JMMWKPVZQRWMSS-UHFFFAOYSA-N isopropanol acetate Natural products CC(C)OC(C)=O JMMWKPVZQRWMSS-UHFFFAOYSA-N 0.000 description 1
- 229940011051 isopropyl acetate Drugs 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-N isovaleric acid Chemical compound CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 1
- 239000012280 lithium aluminium hydride Substances 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920002492 poly(sulfone) Polymers 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- 235000003270 potassium fluoride Nutrition 0.000 description 1
- 239000011698 potassium fluoride Substances 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000010970 precious metal Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 239000002901 radioactive waste Substances 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000005067 remediation Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229910052702 rhenium Inorganic materials 0.000 description 1
- WUAPFZMCVAUBPE-UHFFFAOYSA-N rhenium atom Chemical compound [Re] WUAPFZMCVAUBPE-UHFFFAOYSA-N 0.000 description 1
- 229910052895 riebeckite Inorganic materials 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 239000012945 sealing adhesive Substances 0.000 description 1
- 239000003566 sealing material Substances 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 235000013570 smoothie Nutrition 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
- 229940001584 sodium metabisulfite Drugs 0.000 description 1
- 235000010262 sodium metabisulphite Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000003637 steroidlike Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000003115 supporting electrolyte Substances 0.000 description 1
- 229960001603 tamoxifen Drugs 0.000 description 1
- 229910052713 technetium Inorganic materials 0.000 description 1
- GKLVYJBZJHMRIY-UHFFFAOYSA-N technetium atom Chemical compound [Tc] GKLVYJBZJHMRIY-UHFFFAOYSA-N 0.000 description 1
- 125000005207 tetraalkylammonium group Chemical group 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 229910052723 transition metal Inorganic materials 0.000 description 1
- 150000003624 transition metals Chemical class 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 238000007740 vapor deposition Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
- C25B—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
- C25B9/00—Cells or assemblies of cells; Constructional parts of cells; Assemblies of constructional parts, e.g. electrode-diaphragm assemblies; Process-related cell features
- C25B9/17—Cells comprising dimensionally-stable non-movable electrodes; Assemblies of constructional parts thereof
- C25B9/19—Cells comprising dimensionally-stable non-movable electrodes; Assemblies of constructional parts thereof with diaphragms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1282—Devices used in vivo and carrying the radioactive therapeutic or diagnostic agent, therapeutic or in vivo diagnostic kits, stents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/534—Production of labelled immunochemicals with radioactive label
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Pharmacology & Pharmacy (AREA)
- Cell Biology (AREA)
- Metallurgy (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Electrochemistry (AREA)
- Materials Engineering (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Dispersion Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Electrolytic Production Of Non-Metals, Compounds, Apparatuses Therefor (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/701,438 US5230783A (en) | 1991-05-15 | 1991-05-15 | Electrolytic cell and process for the labeling of proteins and peptides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SA92130072B1 true SA92130072B1 (ar) | 2004-05-24 |
Family
ID=24817377
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SA92130072A SA92130072B1 (ar) | 1991-05-15 | 1992-08-19 | خلية إلكترونية electrolytic cell وعملية لوسم او تعليم labeling البروتينات |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US5230783A (cg-RX-API-DMAC7.html) |
| EP (1) | EP0514187B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2612145B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR0164876B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN1036866C (cg-RX-API-DMAC7.html) |
| AT (1) | ATE171483T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU650337B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2068804C (cg-RX-API-DMAC7.html) |
| DE (1) | DE69227065T2 (cg-RX-API-DMAC7.html) |
| DK (1) | DK0514187T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2120990T3 (cg-RX-API-DMAC7.html) |
| FI (1) | FI108371B (cg-RX-API-DMAC7.html) |
| HU (1) | HU216300B (cg-RX-API-DMAC7.html) |
| IE (1) | IE921540A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL101893A (cg-RX-API-DMAC7.html) |
| MX (1) | MX9202260A (cg-RX-API-DMAC7.html) |
| NO (1) | NO309497B1 (cg-RX-API-DMAC7.html) |
| SA (1) | SA92130072B1 (cg-RX-API-DMAC7.html) |
| SG (1) | SG45300A1 (cg-RX-API-DMAC7.html) |
| TW (1) | TW225560B (cg-RX-API-DMAC7.html) |
| UA (1) | UA27771C2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO1992021019A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA923559B (cg-RX-API-DMAC7.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5590264A (en) * | 1991-04-10 | 1996-12-31 | International Business Machines Corporation | Method and apparatus for graphic association of user dialog displays with primary applications in a data processing system |
| GB9226840D0 (en) * | 1992-12-23 | 1993-02-17 | Unilever Plc | Improvements in or relating to electrochemical reactions |
| US6482309B1 (en) | 1999-10-20 | 2002-11-19 | Oxibio, Inc. | Electrolytic generation of nascent iodine as a method of treatment and for the prevention of infections associated with medical implant devices |
| CN109055968B (zh) * | 2018-07-12 | 2020-07-24 | 芜湖职业技术学院 | 有机电合成电解装置 |
| JP7166531B2 (ja) * | 2018-12-21 | 2022-11-08 | 国立大学法人東京工業大学 | 電気化学的手法を用いたハロゲン化物の製造方法 |
| DE102020122324A1 (de) | 2020-08-26 | 2022-03-03 | Gottfried Wilhelm Leibniz Universität Hannover, Körperschaft des öffentlichen Rechts | Elektrolysezelle, Elektrolysetestsystem und Teststand zum Testen von dichtungsfreien Elektrolysezellen und/oder Elektrolysetestsystemen |
| JPWO2023171617A1 (cg-RX-API-DMAC7.html) * | 2022-03-08 | 2023-09-14 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US341490A (en) * | 1886-05-11 | billings | ||
| DE1187308B (de) * | 1961-10-25 | 1965-02-18 | Licentia Gmbh | Anordnung zur Entregung von Synchronmaschinen |
| US3441490A (en) * | 1964-11-13 | 1969-04-29 | Jungner Instrument Ab | Coulometric titration apparatus |
| US3784453A (en) * | 1970-12-16 | 1974-01-08 | H Dworkin | Process and apparatus for making radioactive labeled protein material |
| BE795902A (fr) * | 1972-02-25 | 1973-08-23 | Rhone Poulenc Sa | Procede de preparation du diiodo-3,5 hydroxy-4benzonitrile et de l'iodo-3 hydroxy-4 nitro-5benzonitrile |
| SU535271A1 (ru) * | 1974-10-22 | 1976-11-15 | Предприятие П/Я В-8046 | Способ получени иодбензола |
| SU517222A1 (ru) * | 1974-10-25 | 1977-06-25 | Институт Биофизики Министерства Здравохранения Ссср | Способ получени препарата бенгальска роза, меченного радиоизотопами йода |
| SU597744A2 (ru) * | 1976-01-09 | 1978-03-15 | Химико-Металлургический Институт Академии Наук Казахской Сср | Электрод с активным слоем |
| SU601925A1 (ru) * | 1976-04-19 | 1979-07-15 | Институт биофизики АН СССР | Способ получени пептидов, меченных изотопами йода |
| US4126034A (en) * | 1978-01-30 | 1978-11-21 | Rheem Manufacturing Company | Method and apparatus for container pressure testing |
| HU179001B (en) * | 1978-05-29 | 1982-08-28 | Chinoin Gyogyszer Es Vegyeszet | Process for preparing 5-halo-6,9alpha-oxido-prostaglandin derivatives |
| US4184937A (en) * | 1978-12-26 | 1980-01-22 | Catalyst Research Corporation | Electrochemical cell for the detection of chlorine |
| GB2081307A (en) * | 1980-07-08 | 1982-02-17 | Engelhard Min & Chem | Use of electrocatalytic anodes in photolysis |
| US4464236A (en) * | 1982-05-10 | 1984-08-07 | The Dow Chemical Company | Selective electrochemical oxidation of organic compounds |
| DE3234665A1 (de) * | 1982-09-18 | 1984-03-22 | Hoechst Ag | Verfahren zur markierung von organselektiven substanzen aus blutbestandteilen mit technetium-99m |
| DE3313655C2 (de) * | 1983-03-02 | 1995-03-23 | Euro Celtique Sa | Pharmazeutisches Jodophor-Präparat |
| DE3367631D1 (en) * | 1983-06-16 | 1987-01-02 | Rhone Poulenc Sante | Process for the electrochemical production of sulfoxides of thioformamide derivatives useful as medicines |
| AU569918B2 (en) * | 1983-10-13 | 1988-02-25 | Ici Australia Operations Proprietary Limited | Redox potential or ph electrode |
| US4859305A (en) * | 1984-08-30 | 1989-08-22 | Mine Safety Appliances Company | Electrochemical cell |
| JPS61106786A (ja) * | 1984-10-30 | 1986-05-24 | Asahi Chem Ind Co Ltd | ｐ−ヨ−ドアニリンの製造方法 |
| US4666570A (en) * | 1984-10-30 | 1987-05-19 | Asahi Kasei Kogyo Kabushiki Kaisha | Process for producing aromatic compound with functional groups |
| JPS61257490A (ja) * | 1985-05-09 | 1986-11-14 | Asahi Chem Ind Co Ltd | 芳香族ジアミンの製造方法 |
| US4644237A (en) * | 1985-10-17 | 1987-02-17 | International Business Machines Corp. | Collision avoidance system |
| JPH01257490A (ja) * | 1988-04-08 | 1989-10-13 | Shiro Nagai | コバルトフリーコリノイドの製造法 |
| GB8817421D0 (en) * | 1988-07-21 | 1988-08-24 | Medisense Inc | Bioelectrochemical electrodes |
-
1991
- 1991-05-15 US US07/701,438 patent/US5230783A/en not_active Expired - Lifetime
-
1992
- 1992-05-12 KR KR1019930703450A patent/KR0164876B1/ko not_active Expired - Fee Related
- 1992-05-12 HU HU9302925A patent/HU216300B/hu not_active IP Right Cessation
- 1992-05-12 JP JP5500138A patent/JP2612145B2/ja not_active Expired - Fee Related
- 1992-05-12 UA UA93004034A patent/UA27771C2/uk unknown
- 1992-05-12 WO PCT/US1992/003943 patent/WO1992021019A1/en not_active Ceased
- 1992-05-14 MX MX9202260A patent/MX9202260A/es unknown
- 1992-05-15 CN CN92104560A patent/CN1036866C/zh not_active Expired - Lifetime
- 1992-05-15 SG SG1996003062A patent/SG45300A1/en unknown
- 1992-05-15 DE DE69227065T patent/DE69227065T2/de not_active Expired - Lifetime
- 1992-05-15 CA CA002068804A patent/CA2068804C/en not_active Expired - Fee Related
- 1992-05-15 TW TW081103818A patent/TW225560B/zh active
- 1992-05-15 AU AU16335/92A patent/AU650337B2/en not_active Ceased
- 1992-05-15 DK DK92304395T patent/DK0514187T3/da active
- 1992-05-15 EP EP92304395A patent/EP0514187B1/en not_active Expired - Lifetime
- 1992-05-15 ES ES92304395T patent/ES2120990T3/es not_active Expired - Lifetime
- 1992-05-15 AT AT92304395T patent/ATE171483T1/de not_active IP Right Cessation
- 1992-05-15 ZA ZA923559A patent/ZA923559B/xx unknown
- 1992-05-15 IL IL10189392A patent/IL101893A/en not_active IP Right Cessation
- 1992-07-01 IE IE154092A patent/IE921540A1/en not_active IP Right Cessation
- 1992-08-19 SA SA92130072A patent/SA92130072B1/ar unknown
-
1993
- 1993-01-26 US US08/008,954 patent/US5246561A/en not_active Expired - Lifetime
- 1993-10-14 NO NO933704A patent/NO309497B1/no unknown
- 1993-11-12 FI FI935023A patent/FI108371B/fi not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Shibahara et al. | Syntheses and electrochemistry of incomplete cubane-type clusters with M3S4 cores (M= molybdenum, tungsten). X-ray structures of [W3S4 (H2O) 9](CH3C6H4SO3) 4. cntdot. 9H2O, Na2 [W3S4 (Hnta) 3]. cntdot. 5H2O, and (bpyH) 5 [W3S4 (NCS) 9]. cntdot. 3H2O | |
| Wang | Electroanalytical techniques in clinical chemistry and laboratory medicine | |
| Annino et al. | The Stereochemistry of Electroreductions. I. Cyclopropyl Halides1 | |
| SA92130072B1 (ar) | خلية إلكترونية electrolytic cell وعملية لوسم او تعليم labeling البروتينات | |
| Rechnitz | Controlled-Potential Analysis: International Series of Monographs on Analytical Chemistry | |
| CN110308262A (zh) | 一种基于TOA萃取的土壤中238Pu/239+240Pu分析方法 | |
| HK1016021B (en) | Electrolytic cell and process for the labeling of proteins and peptides | |
| Roman | The electrodeposition of thorium in natural materials for alpha spectrometry | |
| Broman et al. | Chronopotentiometric Study of Phenylmercuric Ion Adsorption on a Mercury Electrode. | |
| Russell et al. | Tracer electrochemistry of pertechnetate: Chelation of 99mTc by EDTA after controlled-potential reduction at mercury and platinum cathodes | |
| Doménech et al. | Hydrophobic effects in the stabilisation of copper (I) by the macrocyclic ligands 16, 17, 19, 20-tetramethyl-2, 6, 9, 13-tetraaza [14] paracyclophane and 14, 15, 17, 18-tetramethyl-2, 5, 8, 11-tetraaza [12] paracyclophane | |
| Chakravarty et al. | An electrochemical procedure to concentrate 99mTc availed from a zirconium [99Mo] molybdate gel generator | |
| Chi et al. | Electrolytic complexing of glucoheptonate and technetium-99m | |
| Attiyat et al. | Potentiometric selectivity study of crown ethers containing four ring oxygen atoms and benzoxymethyl or carboxylic acid side chains as ionophores for lithium and potassium | |
| LAWSON | Electrochemical and spectroscopic studies of pertechnetate and technetium compounds | |
| Scarano et al. | Mercury-mercurous acetate indicator electrode for potentiometric titrations in anhydrous acetic acid | |
| Sarzanini et al. | Preconcentration and determination of ultratraces of lead and bismuth | |
| Pihlar et al. | Preparation of99mTc-bleomycin with electrogenerated tin (II) ions | |
| Orebaugh et al. | Electrolytic production of uranous nitrate | |
| Pella et al. | Differential controlled-potential coulometry utilizing substoichiometric radioisotope dilution | |
| Klein et al. | Electrolytic preparation of isotopically enriched hard chromium layers on gold backings for nuclear reaction studies | |
| Ismail et al. | Separation and purification of yttrium from strontium through barium sulfate membrane under electric potential | |
| Gruner | Thermodynamic properties of silver chloride-potassium chloride-lithium chloride melts | |
| Brunke | The effects of a proton source on the electrochemical reduction of the chlorinated nitrobenzenes in dimethylsulfoxide, dimethylformamide and acetonitrile | |
| Abbaspour | Electrochemical preparation of technetium methylenediphosphonate (MDP) on the reticulated vitreous carbon electrode |